Im Il Na

1.1k total citations
38 papers, 911 citations indexed

About

Im Il Na is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Im Il Na has authored 38 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Im Il Na's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Im Il Na is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Im Il Na collaborates with scholars based in South Korea. Im Il Na's co-authors include Sung Hyun Yang, Cheol Hyeon Kim, HeeJong Baek, Jae Cheol Lee, Baek‐Yeol Ryoo, Dong‐Yeop Shin, Sunhoo Park, Jin Kyung Lee, Yun Jung Choi and Jin Kyung Rho and has published in prestigious journals such as Cancer, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Im Il Na

35 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Im Il Na South Korea	14	568	508	233	129	125	38	911
W. Thomas Purcell United States	16	518 0.9×	534 1.1×	244 1.0×	83 0.6×	184 1.5×	40	935
Jamal Zekri Saudi Arabia	14	367 0.6×	653 1.3×	190 0.8×	174 1.3×	137 1.1×	68	945
Rubina Qamar United States	12	239 0.4×	479 0.9×	203 0.9×	83 0.6×	210 1.7×	21	908
Seyoung Seo South Korea	15	294 0.5×	369 0.7×	217 0.9×	56 0.4×	112 0.9×	46	676
Jacques Raphael Canada	15	315 0.6×	541 1.1×	187 0.8×	60 0.5×	167 1.3×	70	1.1k
Bo Jin China	17	703 1.2×	527 1.0×	202 0.9×	75 0.6×	147 1.2×	71	972
Chana Weinstock United States	12	301 0.5×	558 1.1×	127 0.5×	99 0.8×	119 1.0×	44	842
Aranzazu González del Alba Spain	15	510 0.9×	274 0.5×	359 1.5×	88 0.7×	280 2.2×	79	870
Sara López‐Tarruella Spain	19	240 0.4×	672 1.3×	228 1.0×	90 0.7×	277 2.2×	89	962
G.P.M. ten Velde Netherlands	15	619 1.1×	452 0.9×	144 0.6×	68 0.5×	72 0.6×	31	921

Countries citing papers authored by Im Il Na

Since Specialization

Citations

This map shows the geographic impact of Im Il Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Im Il Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Im Il Na more than expected).

Fields of papers citing papers by Im Il Na

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Im Il Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Im Il Na. The network helps show where Im Il Na may publish in the future.

Co-authorship network of co-authors of Im Il Na

This figure shows the co-authorship network connecting the top 25 collaborators of Im Il Na. A scholar is included among the top collaborators of Im Il Na based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Im Il Na. Im Il Na is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Yoon Jung, Chang‐Bae Kong, Won Seok Song, et al.. (2024). Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study. Oncology Letters. 27(5). 211–211.

Lim, Sang Moo, Inki Lee, Ilhan Lim, et al.. (2023). A Phase II Study of ¹³¹I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma. Clinical Medicine Insights Oncology. 17. 1373339042–1373339042.

Na, Im Il, et al.. (2023). Art Therapy in Patients with Terminal Cancer and Their Families: A Multiple Case Study. PubMed. 26(4). 171–184.

Kim, Hye-Ryoun, Cheol Hyeon Kim, Sung Hyun Yang, et al.. (2017). Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis. Journal of Cancer Research and Clinical Oncology. 143(11). 2283–2290. 13 indexed citations

Shin, Dong‐Yeop, et al.. (2015). Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation. Blood Research. 50(2). 114–114. 3 indexed citations

Shin, Dong‐Yeop, Yoon Hee Choi, Im Il Na, et al.. (2015). A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site. Cancer Chemotherapy and Pharmacology. 77(1). 163–168. 8 indexed citations

Shin, Dong‐Yeop, Im Il Na, Cheol Hyeon Kim, et al.. (2014). EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas. Journal of Thoracic Oncology. 9(2). 195–199. 249 indexed citations

Park, Jong Ho, et al.. (2013). BRCA1 Gene Mutation in Thymic Malignant Melanoma. The Annals of Thoracic Surgery. 96(2). 677–680. 2 indexed citations

Na, Im Il, et al.. (2012). Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer. Journal of Cancer Research and Therapeutics. 8(3). 373–373. 5 indexed citations

10.

Choi, Yoon Hee, Jin Kyung Lee, Hye Jin Kang, et al.. (2010). Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(12). 1949–1952. 35 indexed citations

11.

Lim, Ilhan, Im Il Na, Du Hwan Choe, et al.. (2010). Evaluation of Adrenal Masses in Lung Cancer Patients Using F-18 FDG PET/CT. Nuclear Medicine and Molecular Imaging. 45(1). 52–58. 16 indexed citations

12.

Rho, Jin Kyung, Yun Jung Choi, Jin Kyung Lee, et al.. (2009). The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Molecular Cancer Research. 7(10). 1736–1743. 55 indexed citations

13.

Kim, Hye-Ryoun, Im Il Na, Yoon Hee Choi, et al.. (2009). The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients. Journal of Cancer Research and Clinical Oncology. 136(4). 547–552. 5 indexed citations

14.

Na, Im Il, Tae Hyun Lee, Du Hwan Choe, et al.. (2008). A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer. European Journal of Cancer. 44(16). 2411–2417. 20 indexed citations

15.

Rho, Jin Kyung, Yun Jung Choi, Jin Kyung Lee, et al.. (2008). Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer. 63(2). 219–226. 190 indexed citations

16.

Yun, Tak, Keun‐Wook Lee, Eun Young Song, et al.. (2007). Non‐myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma. Clinical Transplantation. 21(3). 337–343. 4 indexed citations

17.

Na, Im Il, Tak Yun, Keun‐Wook Lee, et al.. (2006). Acute myelogenous Leukemia in the elderly ($\geq$60): retrospective study of 115 patients. The Korean Journal of Internal Medicine. 70(2). 196–206. 2 indexed citations

18.

Yeo, Winnie, Won Seog Kim, Soo‐Mee Bang, et al.. (2006). Primary gastric lymphoma of T-cell origin: Clinicopathologic features and treatment outcome. Leukemia Research. 30(10). 1253–1258. 7 indexed citations

19.

Lee, Keun‐Wook, Tak Yun, Im Il Na, et al.. (2005). A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma. Journal of Korean Medical Science. 20(4). 598–598. 4 indexed citations

20.

Lee, Keun‐Wook, Seock‐Ah Im, Tak Yun, et al.. (2005). Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer. Japanese Journal of Clinical Oncology. 35(12). 720–726. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact